The HMGB1‑RAGE/TLR‑TNF‑α signaling pathway may contribute to kidney injury induced by hypoxia

Zhang,Cheng; Dong,Hui; Chen,Fengwei; Wang,Yunxia; Ma,Jing; Wang,Guangfa

doi:10.3892/etm.2018.6932

The HMGB1‑RAGE/TLR‑TNF‑α signaling pathway may contribute to kidney injury induced by hypoxia

Authors:
- Cheng Zhang
- Hui Dong
- Fengwei Chen
- Yunxia Wang
- Jing Ma
- Guangfa Wang
View Affiliations

Affiliations: Department of Respiratory and Critical Medicine, Peking University First Hospital, Beijing 100034, P.R. China
Published online on: November 6, 2018 https://doi.org/10.3892/etm.2018.6932
Pages: 17-26
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The hypoxia‑reoxygenation process of obstructive sleep apnea (OSA) may cause oxidative stress injury of the kidney, but the molecular mechanisms are not clear. The present study aimed to investigate whether high mobility group box 1 protein (HMGB1) and its subsequent inflammatory pathway served a role in kidney injury. Adult Sprague Dawley rats were used to establish hypoxia models: Continuous hypoxia, intermittent hypoxia and intermittent hypoxia with hypercapnia. Rat kidney tissues and peripheral blood samples were obtained. Histopathological and ultrastructural changes were observed by light and electron microscopy. Immunohistochemical (IHC) staining was used to detect the distribution of HMGB1. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect the expression of HMGB1, receptor for advanced glycosylation end products (RAGE), toll‑like receptor 4 (TLR4), nuclear factor kappa‑light‑chain‑enhancer of active B cells (NF‑κB) p65 subunit, tumor necrosis factor‑α (TNF‑α), interleukin (IL)‑6, NAD‑dependent protein deacetylase sirtuin‑1 (SIRT1), peroxisome proliferator‑activated receptor (PPAR) mRNA in renal tissues. An ELISA was used to detect the expression of soluble TLR2, TLR4, PPAR‑γ, TNF‑α, IL‑6 in peripheral blood. Hematoxylin & eosin staining demonstrated that there was no serious injury to the kidneys due to hypoxia, with the exception of a certain degree of renal tubular epithelial cell vacuolation. By contrast, ultrastructural changes by electron microscopy were more significant in the hypoxia groups compared with the control, including foot process fusion in the glomerulus and degeneration of mitochondria in the proximal convoluted tubules. IHC also indicated increased expression of HMGB1 and nuclear translocation in the hypoxia groups. The results of the RT‑qPCR demonstrated that hypoxia stimulation increased the expression of HMGB1, PPAR, RAGE and TNF‑α mRNA, and decreased the expression of SIRT1 mRNA in kidney tissues (P<0.05). The results of the ELISA suggested that hypoxia stimulation increased the expression of soluble TLR4, TNF‑α and IL‑6 in the peripheral blood, and decreased the expression of soluble TLR2 and PPAR‑γ. In summary, hypoxia stimulation may cause early renal injury at the subcellular level and increase the expression and translocation of HMGB1. Hypoxia also upregulated the mRNA expression of the HMGB1‑RAGE‑TNF‑α pathway in kidney tissue and increased the expression of soluble TLR4, TNF‑α and IL‑6 in the peripheral blood. This suggested that the HMGB1‑RAGE/TLR‑TNF‑α pathway may contribute to the molecular mechanisms of early renal injury induced by hypoxia. The pathway may contain potential markers for OSA‑associated early renal injury and drug intervention targets in the future.

View Figures

View References

1	Vijayan VK: Morbidities associated with obstructive sleep apnea. Expert Rev Respir Med. 6:557–566. 2012. View Article : Google Scholar : PubMed/NCBI
2	Wu X, Gu W, Lu H, Liu C, Yu B, Xu H, Tang Y, Li S, Zhou J and Shao C: Soluble receptor for advanced glycation end product ameliorates chronic intermittent hypoxia induced renal injury, inflammation, and apoptosis via P38/JNK Signaling Pathways. Oxid Med Cell Longev. 2016:10153902016. View Article : Google Scholar : PubMed/NCBI
3	Adeseun GA and Rosas SE: The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep. 12:378–383. 2010. View Article : Google Scholar : PubMed/NCBI
4	Adams RJ, Appleton SL, Vakulin A, Hanly PJ, McDonald SP, Martin SA, Lang CJ, Taylor AW, McEvoy RD, Antic NA, et al: Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep. 40:Jan 1–2017.doi: 10.1093/sleep/zsw015. PubMed/NCBI
5	Wei Q, Bian Y, Yu F, Zhang Q, Zhang G, Li Y, Song S, Ren X and Tong J: Chronic intermittent hypoxia induces cardiac inflammation and dysfunction in a rat obstructive sleep apnea model. J Biomed Res. 30:490–495. 2016.PubMed/NCBI
6	Zhu S, Li W, Ward MF, Sama AE and Wang H: High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets. 9:60–72. 2010. View Article : Google Scholar : PubMed/NCBI
7	Piccinini AM and Midwood KS: DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010:pii: 672395. 2010. View Article : Google Scholar : PubMed/NCBI
8	Kent BD, Ryan S and McNicholas WT: Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol. 178:475–481. 2011. View Article : Google Scholar : PubMed/NCBI
9	Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, et al: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 117:3216–3226. 2008. View Article : Google Scholar : PubMed/NCBI
10	Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S and Nitecki D: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem. 270:25752–25761. 1995. View Article : Google Scholar : PubMed/NCBI
11	Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, Pittet JF, Tracey K, Thannickal VJ, Abraham E and Zmijewski JW: HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol. 304:L342–L349. 2013. View Article : Google Scholar : PubMed/NCBI
12	Chavakis T, Bierhaus A and Nawroth PP: RAGE (receptor for advanced glycation end products): A central player in the inflammatory response. Microbes Infect. 6:1219–1225. 2004. View Article : Google Scholar : PubMed/NCBI
13	Yu SL, Wong CK, Szeto CC, Li EK, Cai Z and Tam LS: Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus. 24:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
14	Schnare M, Barton GM, Holt AC, Takeda K, Akira S and Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2:947–950. 2001. View Article : Google Scholar : PubMed/NCBI
15	Kozako T, Aikawa A, Shoji T, Fujimoto T, Yoshimitsu M, Shirasawa S, Tanaka H, Honda S, Shimeno H, Arima N and Soeda S: High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer. 131:2044–2055. 2012. View Article : Google Scholar : PubMed/NCBI
16	Michan S and Sinclair D: Sirtuins in mammals: Insights into their biological function. Biochem J. 404:1–13. 2007. View Article : Google Scholar : PubMed/NCBI
17	Villapol S: Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation. Cell Mol Neurobiol. 38:121–132. 2018. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Klune JR, Dhupar R, Cardinal J, Billiar TR and Tsung A: HMGB1: Endogenous danger signaling. Mol Med. 14:476–484. 2008. View Article : Google Scholar : PubMed/NCBI
20	Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, Klarenbach SW, Chin R, Clement FM and Hanly PJ: Nocturnal hypoxia and loss of kidney function. PLoS One. 6:e190292011. View Article : Google Scholar : PubMed/NCBI
21	Hanly PJ and Ahmed SB: Sleep apnea and the kidney: Is sleep apnea a risk factor for chronic kidney disease? Chest. 146:1114–1122. 2014. View Article : Google Scholar : PubMed/NCBI
22	Wu KM, Lin CC, Chiu CH and Liaw SF: Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea. Chest. 137:303–309. 2010. View Article : Google Scholar : PubMed/NCBI
23	Zhang JJ, Peng K, Zhang J, Meng XW and Ji FH: Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. PLoS One. 12:e01720062017. View Article : Google Scholar : PubMed/NCBI
24	Zhang J, Wu Y, Weng Z, Zhou T, Feng T and Lin Y: Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway. Brain Res. 1582:176–186. 2014. View Article : Google Scholar : PubMed/NCBI
25	Lee IC, Ho XY, George SE, Goh CW, Sundaram JR, Pang KKL, Luo W, Yusoff P, Sze NSK and Shenolikar S: Oxidative stress promotes SIRT1 recruitment to the GADD34/PP1α complex to activate its deacetylase function. Cell Death Differ. 25:255–267. 2017. View Article : Google Scholar : PubMed/NCBI
26	Chen DZ, Chen LQ, Lin MX, Gong YQ, Ying BY and Wei DZ: Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ. Microb Pathog. 110:208–213. 2017. View Article : Google Scholar : PubMed/NCBI
27	Wu SH, Wang MJ, Lü J and Chen XQ: Signal transduction involved in lipoxin A4-induced protection of tubular epithelial cells against hypoxia/reoxygenation injury. Mol Med Rep. 15:1682–1692. 2017. View Article : Google Scholar : PubMed/NCBI
28	Zhu H, Li J, Wang S, Liu K, Wang L and Huang L: Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model. Transplantation. 95:1448–1454. 2013. View Article : Google Scholar : PubMed/NCBI
29	Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF and Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 117:2847–2859. 2007. View Article : Google Scholar : PubMed/NCBI
30	Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S and Buhimschi IA: Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol. 182:7244–7253. 2009. View Article : Google Scholar : PubMed/NCBI
31	Henrick BM, Yao XD, Taha AY, German JB and Rosenthal KL: Insights into soluble Toll-Like receptor 2 as a downregulator of virally induced inflammation. Front Immunol. 7:2912016. View Article : Google Scholar : PubMed/NCBI
32	Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, Jones SA, Brennan P, Topley N and Labéta MO: SolubleTLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol. 183:506–517. 2009. View Article : Google Scholar : PubMed/NCBI
33	Nardelli LM, Rzezinski A, Silva JD, Maron-Gutierrez T, Ornellas DS, Henriques I, Capelozzi VL, Teodoro W, Morales MM, Silva PL, et al: Effects of acute hypercapnia with and without acidosis on lung inflammation and apoptosis in experimental acute lung injury. Respir Physiol Neurobiol. 205:1–6. 2015. View Article : Google Scholar : PubMed/NCBI
34	Chonghaile Ni M, Higgins BD, Costello JF and Laffey JG: Hypercapnic acidosis attenuates severe acute bacterial pneumonia-induced lung injury by a neutrophil-independent mechanism. Crit Care Med. 36:3135–3144. 2008. View Article : Google Scholar : PubMed/NCBI
35	Takeshita K, Suzuki Y, Nishio K, Takeuchi O, Toda K, Kudo H, Miyao N, Ishii M, Sato N, Naoki K, et al: Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-[kappa]B activation. Am J Respir Cell Mol Biol. 29:124–132. 2003. View Article : Google Scholar : PubMed/NCBI